A similar effect of simvastatin has been shown on tumor-associated macrophages and tumor cells in a non-small-cell lung cancer (NSCLC) cell line; simvastatin attenuated TGF-β, which, in turn, remodeled the tumor microenvironment and suppressed EMT [42]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.